Inhibiting the expression of BCL-2 protein using BH3-mimetic drugs can disrupt the intrinsic apoptotic pathway in MPM cell lines. Thus significantly enhancing the apoptosis (cell death) of tumor cells, and improving the survival time. Scientists from the Olivia...
read more
Scientists from St. John's University, Queens, have provided an excellent drug-delivery method for the treatment of malignant pleural mesothelioma. This newly designed and tested method uses chitosan containing lipid vesicles called Chitosome as carriers for the...
read more
The state of Montana won a district court lawsuit that ruled that National Indemnity Co. (NIC), an insurance company wholly owned by Berkshire Hathaway, was liable for almost $100 million in damages entitled to asbestos victims in the small mountain town of Libby....
read more
Linda Reinstein lost her husband, Alan, in 2006 due to a valiant fight against mesothelioma. With their daughter and Linda by his side, Alan succumbed to the complications of his diagnosis, which was medically connected to elongated exposure to asbestos. "For each...
read more
Nearly three years ago, a group of U.S. senators, including Jeff Merkley (D-Oregon), Bernie Sanders (I-VT) and Sen. Dianne Feinstein, (D-CA) co-sponsored legislation banning the importation and use of asbestos in the United States. The bill would save thousands of...
read more
A recent New Jersey appeals court ruling to revive two lawsuits that alleged talc in Johnson & Johnson Baby Powder causing ovarian cancer could lead to the reinstatement of 1,000 similar suits, Bloomberg News reported. “There are approximately 1,000 ovarian cancer...
read more
Updated phase III clinical trials indicate that a combination of two immunotherapy drugs can improve prognosis in patients with non-removable mesothelioma tumors, according to scientists from the Netherlands Cancer Institute. The trial, called checkmate 743, is a...
read more
An analysis of mesothelioma patients who underwent cytoreductive surgery concludes that surgical treatment can improve the survival rate of a patient and should be the first choice for early treatment. A study from the Annals of Surgical Oncology examined the survival...
read more
TCR2 Therapeutics announced on July 26 the first positive results for a new T-cell therapy to treat cancer patients, according to the press release on July 26th. The first five patients treated in phase I of the clinical trial showed mesothelin-expressing tumor...
read more
A new study shows that near-infrared phototherapy could be a promising treatment for individuals with pleural mesothelioma, according to a press release from Nagoya University. The study, which tested mice and 12 human cell lines with malignant tumors, concluded that...
read more